Delivery Order SPE2DB20D3103-SPE2DB24FP7F4
Award Date
7/31/24
Potential Completion Date
8/1/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FEBUXOSTAT 40 MG TABLET 30S. The contract has a firm fixed price of $1,494.03 and an ultimate completion date of May 20, 2025. The award was made on May 19, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of febuxostat 40 mg tablets. The contract has a firm fixed price, with a ceiling value of $1,273.48, and a period of performance ending on June 23, 2025. The contract is not set aside and was awarded on June 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,797.97, is for the delivery of febuxostat 40 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of April 1, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit organization and subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of febuxostat 40 mg tablets, a pharmaceutical product, to support military treatment programs and facilities. The firm fixed price contract has a ceiling value of $2,946.00 and a period of performance through April 1, 2024. In addition to this delivery order, AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Febuxostat 40 mg tablets, with a ceiling value of $2,408.89 and a performance period through May 12, 2023. The contract is an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,236.52 firm-fixed-price contract is for the supply of febuxostat 40 mg tablets. There is no set-aside designation. Amerisourcebergen holds multiple Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, for providing a wide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,280.57 fixed-price contract is for the supply of febuxostat 40 mg tablets, a medication used to treat gout. The contract has an ultimate completion date of July 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Febuxostat 40 mg tablets. The contract has a firm fixed price of $1,218.40 and a completion date of August 26, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,633.92, is a delivery order contract with a firm fixed price for the supply of febuxostat 40 mg tablets. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Febuxostat 80 mg tablets. The fixed-price delivery order has a ceiling value of $1,224.27 and a period of performance through June 20, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp has a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...